New Multiple Sclerosis Therapy Promising in Early Trial
Experimental drug, ocrelizumab, reduced active brain lesions in study patientsContinue Reading
Experimental drug, ocrelizumab, reduced active brain lesions in study patientsContinue Reading
In California study, 1 in 5 children at some schools intentionally unvaccinated, raising concernsContinue Reading
Provides relief up to 72 hoursContinue Reading
Executive order signed in response to tripling of prescription drug shortagesContinue Reading
The best way to avoid asthma attacks is to avoid the triggers that cause them, experts sayContinue Reading
Common medications might block action of dementia drugs like AriceptContinue Reading
People with Lynch syndrome, a hereditary form of cancer, might benefit from 2 tablets a day: studyContinue Reading
Research in gay and bisexual men suggests it reduces infections, lesionsContinue Reading
Majority treated had 75 percent improvement in skin symptoms, study findsContinue Reading
U.S. Drug Enforcement Administration aims to keep unused medicines away from abusersContinue Reading
Analysis found it only protected healthy adults 60 percent of the timeContinue Reading
Rats given a marijuana-like drug showed disrupted communications between brain regions, or ‘cognitive chaos’Continue Reading
Three gene types in heart patients and certain medications affected risk of dangerous clotsContinue Reading
Study found patient’s overall health, injury severity more likely to determine survivalContinue Reading
© 2021 TheHealthCast.com - All Rights Reserved.